Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 5:34 pm Sale |
2025-02-27 | 13G | BiomX Inc. PHGE |
Cystic Fibrosis Foundation | 2,494,110 9.990% |
-1,600,448 (-39.09%) |
Filing History |
| 2025-02-14 4:05 pm Purchase |
2024-09-30 | 13G | BiomX Inc. PHGE |
Cystic Fibrosis Foundation | 4,094,558 19.990% |
3,161,500 (+338.83%) |
Filing History |
| 2024-03-26 4:30 pm Purchase |
2024-03-26 | 13G | BiomX Inc. PHGE |
Cystic Fibrosis Foundation | 933,058 15.600% |
477,827 (+104.96%) |
Filing History |
| 2024-01-30 4:05 pm Purchase |
2024-01-30 | 13G | BiomX Inc. PHGE |
Cystic Fibrosis Foundation | 455,232 9.900% |
180,133 (+65.48%) |
Filing History |
| 2023-03-08 5:22 pm Purchase |
2023-02-27 | 13G | BiomX Inc. PHGE |
Cystic Fibrosis Foundation | 275,099 8.100% |
275,099 (New Position) |
Filing History |
| 2022-12-19 06:05 am Purchase |
2022-12-08 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Cystic Fibrosis Foundation | 5,168,732 19.900% |
5,168,732 (New Position) |
Filing History |